Keywords
Immune Response
Rose Extract
Pierre De Ronsard
Cytokine Levels
CD4 T-Cells
How to Cite
Abstract
Background. Red rose extract is known to have anti-inflammatory and immune-modulation effects. In this study, the red rose extract was tested on CD4+T lymphocytes in vitro, and cytokine response was evaluated.
Materials and Methods. The red rose (Rosa Rosaceae - Pierre de Ronsard) extract used in this study was prepared and stored at -20° C until use. CD4+T-cells were seeded in 96-well plates at 313,500 cells/well in 100μ l cell culture medium in duplicate. One-half of the wells were used for biomarker screening in the culture medium, and the other half was used for cytotoxicity assay. Twenty-four hours after plating, the cells were treated in duplicate with 100μ l of the red rose extract diluted at 0.5%, 0.1%, 0.05%, 0.01% and 0.005% (v/v) in the cell culture medium or with culture medium only as control for 72 hours. Some other wells were allocated for untreated cells, and cells treated with the rose extract at 0.005% for 48-h incubation time.
Results. Several cytokines (GRO; IFN-γ; IL-1α, 6, 10; MCP-1; RANTES; TGF-β1; TIMP 1, 2; Ang1, Ang2; G-CSF; MMP-9; and VEGF R2) were elevated. Except for MMP-9, which had fold changes > 2, other cytokines were minimally elevated at various concentrations and timing of rose extract treatment. None of the mentioned cytokines were less than 0.8-fold after treatment with the rose extract. Cytotoxicity assay revealed insignificant changes in the viability of T-cells.
Conclusions. There was a mild elevation in few inflammatory markers by CD4+ T-lymphocytes after in vitro treatment with the red rose extract (Rosa Rosacea - Pierre De Ronsard). Further in vitro and in vivo studies are required to evaluate the benefits of the red rose extract in immune regulation.
References
Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity. 2009;33(3-4):197–207. Available from: https://doi.org/10.1016/j.jaut.2009.09.008
Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmunity Reviews. 2003;2(3):119–125. Available from: https://doi.org/10.1016/S1568-9972(03)00006-5
Willame C, Dodd C, van der Aa L, Picelli G, Emborg H-D, Kahlert J, et al. Incidence rates of autoimmune diseases in european healthcare databases: a contribution of the ADVANCE project. Drug Safety. 2021;44(3):383–395. Available from: https://doi.org/10.1007/s40264-020-01031-1
Bagatini MD, Cardoso AM, Reschke CR, Carvalho FB. Immune system and chronic diseases 2018. Journal of Immunology Research. 2018;2018:1–2. Available from: https://doi.org/10.1155/2018/8653572
Nediani C, Giovannelli L. Oxidative stress and inflammation as targets for novel preventive and therapeutic approches in non communicable diseases. Antioxidants. 2020;9(4):290. Available from: https://doi.org/10.3390/antiox9040290
Duan L, Rao X, Sigdel KR. Regulation of inflammation in autoimmune disease. Journal of Immunology Research. 2019;2019:1–2. Available from: https://doi.org/10.1155/2019/7403796
Ménétrier-Caux C, Ray-Coquard I, Blay J-Y, Caux C. Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines? Journal for ImmunoTherapy of Cancer. 2019;7(1):85. Available from: https://doi.org/10.1186/s40425-019-0549-5
P Abraham B, H Sellin J. Lymphopenia in inflammatory bowel disease patients on immunosuppressive medications. Journal of Gastroenterology and Hepatology Research. 2016;5(1):1890–1894. Available from: https://doi.org/10.17554/j.issn.2224-3992.2016.05.595
Xia A, Zhang Y, Xu J, Yin T, Lu X-J. T cell dysfunction in cancer immunity and immunotherapy. Frontiers in Immunology. 2019;10:1719. Available from: https://doi.org/10.3389/fimmu.2019.01719
Bascones-Martinez A, Mattila R, Gomez-Font R, Meurman J. Immunomodulatory drugs: oral and systemic adverse effects. Medicina Oral Patología Oral y Cirugia Bucal. 2014;19(1):e24–e31. Available from: https://doi.org/10.4317/medoral.19087
Bamgbola O. Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Therapeutic Advances in Endocrinology and Metabolism. 2016;7(3):110–127. Available from: https://doi.org/10.1177/2042018816641580
Claes K, Meier-Kriesche H-U, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrology Dialysis Transplantation. 2011;27(2):850–857. Available from: https://doi.org/10.1093/ndt/gfr238
Salama AD. Chapter 6 Renal toxicities associated with immunomodulatory drugs. the kidney in systemic autoimmune diseases. 2007;7:107–119. Available from: https://doi.org/10.1016/S1571-5078(07)07006-7
Luckheeram RV, Zhou R, Verma AD, Xia B. CD4+T cells: differentiation and functions. Clinical and Developmental Immunology. 2012;2012:1–12. Available from: https://doi.org/10.1155/2012/925135
Kumari J, Selvan SR, Becart S, Chattopadhyay S, Dalmo RA. Cell-mediated immunity and vaccines. Journal of Immunology Research. 2014;2014:1–2. Available from: https://doi.org/10.1155/2014/632632
Jahromi HK, Jashni HK, Dialemeh S. Effect of Damask Rose extract on FSH, LH and testosterone hormones in rats. Int J Med Res Health Sci. 2016;5(S):267-271. Available from: https://www.ijmrhs.com/medical-research/effect-of-damask-rose-extract-on-fsh-lh-and-testosterone-hormones-in-rats.pdf
Akram M, Riaz M, Munir N, Akhter N, Zafar S, Jabeen F, et al. Chemical constituents, experimental and clinical pharmacology of Rosa damascena: a literature review. Journal of Pharmacy and Pharmacology. 2019;72(2):161–174. Available from: https://doi.org/10.1111/jphp.13185
Mohebitabar S, Shirazi M, Bioos S, Rahimi R, Malekshahi F, Nejatbakhsh F. Therapeutic efficacy of rose oil: a comprehensive review of clinical evidence. Avicenna J Phytomed. 2017;7(3):206-213. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511972/
Hamidpour R, Hamidpour S, Hamidpour M, Marshall V, Hamidpour R. Pelargonium graveolens (Rose geranium) - a novel therapeutic agent for antibacterial, antioxidant, antifungal and diabetics. Archives in Cancer Research. 2017;05(01). Available from: https://doi.org/10.21767/2254-6081.1000134
Arokiaraj MC, Menesson E. Novel anti-inflammatory and immunomodulation effects of rose on the endothelium in normal and hypoxic invitro conditions. Angiologia e Cirurgia Vascular. 2019;15(4):238-248. Available from: https://doi.org/10.48750/acv.221
Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9(5):1076. Available from: https://doi.org/10.3390/cells9051076
Rybakowski JK. Matrix metalloproteinase-9 (MMP9)—a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovascular Psychiatry and Neurology. 2009;2009:1–7. Available from: https://doi.org/10.1155/2009/904836
Das A, Fanslow W, Cerretti D, Warren E, Talarico N, McGuire P. Angiopoietin/Tek interactions regulate MMP-9 expression and retinal neovascularization. Laboratory Investigation. 2003;83(11):1637–1645. Available from: https://doi.org/10.1097/01.LAB.0000097189.79233.D8
Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A. Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Investigative Opthalmology & Visual Science. 2007;48(9):4360. Available from: https://doi.org/10.1167/iovs.06-1234
Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by ANG-1. Journal of Cerebral Blood Flow & Metabolism. 2005;25(11):1491–1504. Available from: https://doi.org/10.1038/sj.jcbfm.9600148
Nowicki M, Wierzbowska A, Małachowski R, Robak T, Grzybowska-Izydorczyk O, Pluta A, et al. VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment. Annals of Hematology. 2017;96(12):2103–2112. Available from: https://doi.org/10.1007/s00277-017-3133-4
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology. 2000;2(10):737–744. Available from: https://doi.org/10.1038/35036374
Johnson C, Sung H-J, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues. Circulation Research. 2004;94(2):262–268. Available from: https://doi.org/10.1161/01.RES.0000111527.42357.62
Huang P-H, Chen Y-H, Wang C-H, Chen J-S, Tsai H-Y, Lin F-Y, et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow–derived endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29(8):1179–1184. Available from: https://doi.org/10.1161/ATVBAHA.109.189175
Alawo DOA, Tahir TA, Fischer M, Bates DG, Amirova SR, Brindle NPJ. Regulation of Angiopoietin signalling by Soluble Tie2 ectodomain and engineered ligand trap. Scientific Reports. 2017;7(1). Available from: https://doi.org/10.1038/s41598-017-03981-6
Balaji S, Han N, Moles C, Shaaban AF, Bollyky PL, Crombleholme TM, et al. Angiopoietin-1 improves endothelial progenitor cell–dependent neovascularization in diabetic wounds. Surgery. 2015;158(3):846–856. Available from: https://doi.org/10.1016/j.surg.2015.06.034
Wang W, Li D, Xiang L, Lv M, Tao L, Ni T, et al. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9. Cell Adhesion & Migration. 2019;13(1):272–283. Available from: https://doi.org/10.1080/19336918.2019.1639303
Xu X, Zheng L, Yuan Q, Zhen G, Crane JL, Zhou X, et al. Transforming growth factor-β in stem cells and tissue homeostasis. Bone Research. 2018;6(1):2. Available from: https://doi.org/10.1038/s41413-017-0005-4
Zha Z, Bucher F, Nejatfard A, Zheng T, Zhang H, Yea K, et al. Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation. Proceedings of the National Academy of Sciences. 2017;114(33):E6867–E6874. Available from: https://doi.org/10.1073/pnas.1706915114
Singh S, Anshita D, Ravichandiran V. MCP-1: function, regulation, and involvement in disease. International Immunopharmacology. 2021;101:107598. Available from: https://doi.org/10.1016/j.intimp.2021.107598
Sawant KV, Poluri KM, Dutta AK, Sepuru KM, Troshkina A, Garofalo RP, et al. Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions. Scientific Reports. 2016;6(1):33123. Available from: https://doi.org/10.1038/srep33123
Azhar N, Namas RA, Almahmoud K, Zaaqoq A, Malak OA, Barclay D, et al. A putative “chemokine switch” that regulates systemic acute inflammation in humans. Scientific Reports. 2021;11(1):9703. Available from: https://doi.org/10.1038/s41598-021-88936-8
Knight BE, Kozlowski N, Havelin J, King T, Crocker SJ, Young EE, et al. TIMP-1 Attenuates the development of inflammatory pain through MMP-dependent and receptor-mediated cell signaling mechanisms. Frontiers in Molecular Neuroscience. 2019;12. Available from: https://doi.org/10.3389/fnmol.2019.00220
Hirano T. IL-6 in inflammation, autoimmunity and cancer. International Immunology. 2020;33(3):127–148. Available from: https://doi.org/10.1093/intimm/dxaa078
Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871–891. Available from: https://doi.org/10.1016/j.immuni.2019.03.020
Di Paolo NC, Shayakhmetov DM. Interleukin 1α and the inflammatory process. Nature Immunology. 2016;17(8):906–913. Available from: https://doi.org/10.1038/ni.3503
Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Annals of the New York Academy of Sciences. 2015;1347(1):45–51. Available from: https://doi.org/10.1111/nyas.12726
Park SA, Jeong MS, Ha K-T, Jang SB. Structure and function of vascular endothelial growth factor and its receptor system. BMB Reports. 2018;51(2):73–78. Available from: https://doi.org/10.5483/BMBRep.2018.51.2.233
Karagiannidis I, Jerman SJ, Jacenik D, Phinney BB, Yao R, Prossnitz ER, et al. G-CSF and G-CSFR modulate CD4 and CD8 T Cell responses to promote colon tumor growth and are potential therapeutic targets. Frontiers in Immunology. 2020;11. Available from: https://doi.org/10.3389/fimmu.2020.01885
Li X, Liu R, Zhao Y, Gao N, Jin X, Gao X, et al. The extract from the roots of Rose odorata sweet var. gigantean (Coll. et Hemsl.) Rehd. et Wils attenuates DSS-induced ulcerative colitis by regulating the Nrf2/NF-κB signaling pathways. RSC Advances. 2020;10(16):9450–9461. Available from: https://doi.org/10.1039/C9RA10747A
Gruenwald J, Uebelhack R, Moré MI. Rosa canina – Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis – a systematic review. Phytomedicine. 2019;60:152958. Available from: https://doi.org/10.1016/j.phymed.2019.152958
Wu M, Feng H, Song J, Chen L, Xu Z, Xia W, et al. Structural elucidation and immunomodulatory activity of a neutral polysaccharide from the Kushui Rose (Rosa setate x Rosa rugosa) waste. Carbohydrate Polymers. 2020;232:115804. Available from: https://doi.org/10.1016/j.carbpol.2019.115804
Al-Oqail MM, Farshori NN, Al-Sheddi ES, Al-Massarani SM, Saquib Q, Siddiqui MA, et al. Oxidative stress mediated cytotoxicity, cell cycle arrest, and apoptosis induced by Rosa damascena in Human cervical cancer HeLa cells. Oxidative Medicine and Cellular Longevity. 2021;2021:1–11. Available from: https://doi.org/10.1155/2021/6695634
Zhao L, Qiu J, Yin X, Zhang N, Wu W, Wang C, et al. Blossom and bee pollen from Rosa rugosa as potential intervention for acne caused by excessive androgen secretion in golden hamster acne model. Food and Agricultural Immunology. 2019;30(1):1174–1188. Available from: https://doi.org/10.1080/09540105.2019.1674788
Firdous A, Sarwar S, Shah FA, Tabasum S, Zeb A, Nadeem H, et al. Contribution of attenuation of TNF-α and NF-κB in the anti-epileptic, anti-apoptotic and neuroprotective potential of Rosa webbiana fruit and its chitosan encapsulation. Molecules. 2021;26(8):2347. Available from: https://doi.org/10.3390/molecules26082347
Wu M, Li W, Zhang Y, Shi L, Xu Z, Xia W, et al. Structure characteristics, hypoglycemic and immunomodulatory activities of pectic polysaccharides from Rosa setate x Rosa rugosa waste. Carbohydrate Polymers. 2021;253:117190. Available from: https://doi.org/10.1016/j.carbpol.2020.117190
Kim K, Park Y, Jang H, Lee S, Lee S, Yun B, et al. Rugosic acid A, derived from Rosa rugosa Thunb., is novel inhibitory agent for NF‐κB and IL‐6/STAT3 axis in acute lung injury model. Phytotherapy Research. 2020;34(12):3200–3210. Available from: https://doi.org/10.1002/ptr.6767
Zhou S-F, Chen X-W. Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Drug Design, Development and Therapy. 2015;2015(9):2941-2946. Available from: https://doi.org/10.2147/DDDT.S86396
Lee S-H, Choi S-H, Lee I-S, Kim Y, An E-J, Jang H-J. Anti-inflammatory effect of Rosa laevigata extract on in vitro and in vivo model of allergic asthma via the suppression of IgE and related cytokines. Molecular & Cellular Toxicology. 2020;16(2):119–127. Available from: https://doi.org/10.1007/s13273-019-00063-8
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.